F Tonelli, R Valanzano. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » Adenomatous Polyposis Coli/drug therapyAdenomatous Polyposis Coli/surgeryAdolescentAdultFemaleHumansMaleMiddle AgedPostoperative PeriodSulindac/therapeutic use
Substances: See more » Sulindac
Year: 1993 PMID: 8105347 DOI: 10.1016/0140-6736(93)92108-6
Source DB: PubMed Journal: Lancet ISSN: 0140-6736 Impact factor: 79.321